Guest Editors
Prof. Ning Wei
Email: ning.wei@einsteinmed.edu
Affiliation: Department of Oncology (Medical Oncology), Albert Einstein College of Medicine, Bronx, NY 10461, USA
Homepage:
Research Interests: Cancer Pharmacology&Drug Discovery
Prof. Giuseppe Nocentini
Email: giuseppe.nocentini@unipg.it
Affiliation: Department of Medicine, University of Perugia, 06129 Perugia, Italy
Homepage:
Research Interests: Pharmacology, Immunotoxicology, Pharmacoimmunology, Oncopharmacology
Summary
Advances in cancer pharmacology continue to transform the landscape of oncology by driving innovative therapies that target specific molecular mechanisms of cancer progression. This special issue aims to bring together cutting-edge research focused on the pharmacological treatment of cancer, with an emphasis on novel drug development, resistance mechanisms, and the optimization of therapeutic regimens.
Submissions are encouraged across a broad spectrum of topics, including but not limited to:
Targeted therapies and precision medicine approaches
Mechanisms of drug resistance in cancer treatment
Pharmacokinetics and pharmacodynamics of anticancer drugs
Combination therapies and their synergistic effects
Development of novel small molecules, biologics, and immunotherapies
Preclinical and clinical pharmacology studies
Drug repurposing for cancer treatment
Toxicity, safety, and quality of life considerations in cancer pharmacotherapy
We welcome original research articles, reviews, and clinical studies that explore innovative solutions to challenges in cancer pharmacology, with the goal of improving patient outcomes and advancing the field of oncology.
Keywords
Targeted Therapy, Drug Resistance, Immunopharmacology, Novel Anticancer Agents
Login
Register
Submit a Paper
Propose a Special lssue